BridgeMD
New treatment option for Stroke
Official title Targeted TDCS to Enhance Speech-Language Treatment Outcome in Persons With Chronic Post-Stroke Aphasia.
ClinicalTrials.gov ID: NCT04432883
What this study is testing
- What it's testing
- 62 patients who are one year post stroke and have Aphasia as a result of that stroke will be recruited. Participants will have 4 assessment sessions and 15 treatment sessions.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 85
You may be able to join if
- aged 25-85
- must be greater than 6 months post-stroke
- must have a diagnosis of aphasia based on impaired performance on the Western Aphasia Battery-Revised, Boston Naming Test, or during discourse...
- must be left-hemisphere dominant as demonstrated by aphasia onset subsequent to left hemisphere damage
- must be stimulable for naming
You likely can't join if
- comorbid neurological disease.
- damage to the anterior right hemisphere.
- significant mood disorder.
- substance/alcohol dependence or abuse within the past year
- presence of any implanted electrical device or contraindications to tDCS or MRI
- recent medical instability (within 4 weeks)
See the full eligibility criteria
- aged 25-85
- must be greater than 6 months post-stroke
- must have a diagnosis of aphasia based on impaired performance on the Western Aphasia Battery-Revised, Boston Naming Test, or during discourse production
- must be left-hemisphere dominant as demonstrated by aphasia onset subsequent to left hemisphere damage
- must be stimulable for naming
- comorbid neurological disease.
- damage to the anterior right hemisphere.
- significant mood disorder.
- substance/alcohol dependence or abuse within the past year
- presence of any implanted electrical device or contraindications to tDCS or MRI
- recent medical instability (within 4 weeks)
- pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Albuquerque, New Mexico, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Albuquerque, New Mexico, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.